CAR-T-Zell-Therapie Logo
  • Aktuelles
  • Studien
  • Zentren
  • Patienteninfos
  • Fortbildung
  • Zulassungen
  • Fachbeiträge
  • Community
  • Login
Suche
zurück zur Zentren Übersicht
Nordrhein-Westfalen

Universitätsklinikum Essen - Klinik für Hämatologie und Stammzelltransplantation

Hufelandstraße 55
D-45147 Essen
Leitung: Univ.-Prof. Dr. med. H. C. Reinhardt

Studien

  • INTEGRATE ATMP
  • A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
  • A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation (KarMMa-9)
  • Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients (DALY 2-EU)

Kontakt

Univ.-Prof. Dr. med. Bastian von Tresckow
bastian.vontresckow@uk-essen.de
+49 (0)201-723-85557 (Sekretariat C. Jakubowski)
Marcel Teichert
CAR-T-Zell Koordinator
marcel.teichert@uk-essen.de
+49 (0)201 723 86183

Studien

  • INTEGRATE ATMP
  • A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
  • A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation (KarMMa-9)
  • Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients (DALY 2-EU)
  • Aktuelles
  • Studien
  • Zentren
  • Patienteninfos
  • Fortbildung
  • Fachbeiträge
  • Zulassungen
  • Community
  • CARTakut
  • Aktuelles
  • Studien
  • Zentren
  • Patienteninfos
  • Fortbildung
  • Fachbeiträge
  • Zulassungen
  • Community
  • CARTakut
Ein Projekt von:
In Zusammenarbeit mit:
  • Impressum
  • Datenschutz
  • Cookie Einstellungen